Quick Answer
Anixa Biosciences Inc reported Research And Development Expense of $5.07 million for the year ending 2025.
- Anixa Biosciences Inc showed a decrease of -20.7% in Research And Development Expense from 2024 to 2025.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2010 to 2025), Anixa Biosciences Inc's Research And Development Expense has grown by 68.6%.
- Historical annual values: Fiscal year 2025: $5.07 million | Fiscal year 2024: $6.40 million | Fiscal year 2023: $4.77 million | Fiscal year 2022: $6.70 million | Fiscal year 2021: $6.19 million | Fiscal year 2020: $4.38 million | Fiscal year 2019: $5.47 million | Fiscal year 2018: $6.81 million | Fiscal year 2017: $1.60 million | Fiscal year 2016: $1.56 million | Fiscal year 2012: $2.21 million | Fiscal year 2011: $3.12 million | Fiscal year 2010: $3.01 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: